Profil
Rick Kendall formerly worked at PYC Therapeutics Ltd., as Non-Executive Director in 2017, Amgen Australia Pty Ltd., as Executive Director-Oncology Research, and Kite Pharma, Inc., as Vice President-Research.
Anciens postes connus de Rick Kendall
| Sociétés | Poste | Fin |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 23/10/2017 |
| Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
| Amgen Australia Pty Ltd. |
